Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

36.78
+1.303.66%
Pre-market: 36.810.0300+0.08%09:06 EDT
Volume:364.65K
Turnover:13.30M
Market Cap:1.12B
PE:-56.22
High:36.85
Open:35.98
Low:34.94
Close:35.48
52wk High:44.28
52wk Low:17.72
Shares:30.55M
Float Shares:28.22M
Volume Ratio:1.07
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6542
EPS(LYR):-0.8334
ROE:-4.20%
ROA:-1.36%
PB:2.39
PE(LYR):-44.13

Loading ...

Castle Biosciences Q2 Adj. EPS $(0.07) Beats $(0.41) Estimate, Sales $103.546M Beat $86.240M Estimate

Benzinga Earnings
·
Jul 31

Castle Biosciences - Raises Fy2026 Revenue Guidance to $365-$375 Mln

THOMSON REUTERS
·
Jul 31

Castle Biosciences - Expects Positive Adj Ebitda for Q3, Q4, and Fy2026

THOMSON REUTERS
·
Jul 31

Castle Biosciences CEO Derek Maetzold Disposes of $202,507 in Common Shares

Reuters
·
Jul 30

SciBase CEO Pia Renaudin to Step Down as Board Launches Successor Search

Reuters
·
Jul 28

Castle Biosciences CEO Derek J. Maetzold Disposes of 550 Common Shares Worth $12,606‬‬

Reuters
·
Jul 17

Castle Biosciences Gets New York State Department of Health Approval of AdvanceAD-Tx Test

MT Newswires Live
·
Jul 15

Castle Biosciences Announces New York State Department of Health Approval of Its Advancead-tx™ Test

THOMSON REUTERS
·
Jul 15

Castle Biosciences Schedules Second-quarter Results Webcast

Reuters
·
Jul 09

Castle Biosciences COO Kristen Oelschlager Sells 8,586 Shares for $209,041.2

Reuters
·
Jul 07

Castle Biosciences Says Decisiondx-melanoma I31-slnb Beats MIA Nomogram in Prospective SLNB Risk Study

Reuters
·
Jun 26

Castle Biosciences Initiated at Buy by Roth Capital

Dow Jones
·
Jun 25

Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook

TIPRANKS
·
Jun 25

Castle Biosciences CFO Frank Stokes set for Houston Business Journal CFO Awards event

Reuters
·
Jun 23

Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal

THOMSON REUTERS
·
Jun 23

Castle Biosciences grants 204,925 inducement RSUs to 172 employees under 2022 plan

Reuters
·
Jun 19

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 19

Castle Biosciences COO Kristen Oelschlager sells 8,587 shares worth $177,230.77

Reuters
·
Jun 19

Castle Biosciences CEO Derek J. Maetzold reports disposal of common shares worth $43,371.58

Reuters
·
Jun 18

Castle Biosciences says TissueCypher Barrett’s esophagus test tops 100,000 orders

Reuters
·
Jun 16